{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T10:28:40Z","timestamp":1781173720024,"version":"3.54.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1982,10,1]],"date-time":"1982-10-01T00:00:00Z","timestamp":402278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"published-print":{"date-parts":[[1982,10]]},"DOI":"10.1007\/bf01059033","type":"journal-article","created":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T15:18:33Z","timestamp":1107011913000},"page":"495-506","source":"Crossref","is-referenced-by-count":36,"title":["Kinetic study of smoking marijuana"],"prefix":"10.1007","volume":"10","author":[{"given":"Gene","family":"Barnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia -Whei N.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Perez-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[1982,10,1]]},"reference":[{"key":"BF01059033_CR1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1021\/np50008a001","volume":"43","author":"C. E. Turner","year":"1980","unstructured":"C. E. Turner, M. A. Elsohly, and E. G. Boeren. Constituents of cannabis sativa L. XVI: a review of the natural constituents.J. Natural Products 43:169\u2013234 (1980).","journal-title":"J. Natural Products"},{"key":"BF01059033_CR2","first-page":"80","volume-title":"Marijuana Research Findings: 1980","year":"1980","unstructured":"R. C. Petersen, (ed.),Marijuana Research Findings: 1980. U.S. Government Printing Office, Washington, D.C., National Institute on Drug Abuse, DHHS Publication (ADM) 80\u20131001 (1980)."},{"key":"BF01059033_CR3","doi-asserted-by":"crossref","first-page":"201S","DOI":"10.1002\/j.1552-4604.1981.tb02596.x","volume":"21","author":"M. Perez-Reyes","year":"1981","unstructured":"M. Perez-Reyes, S. M. Owens, and S. DiGuiseppi. The clinical pharmacology and dynamics of marijuana cigarette smoking.J. Clin. Pharmacol. 21:201S-207S (1981).","journal-title":"J. Clin. Pharmacol."},{"key":"BF01059033_CR4","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jps.2600640546","volume":"64","author":"J. H. Holley","year":"1975","unstructured":"J. H. Holley, K. W. Hadley, and C. E. Turner. Constituents of cannabis sativa L. XI: Cannabidiol and cannabichromene in samples of known geographic origin.J. Pharm. Sci. 64:892\u2013895 (1975).","journal-title":"J. Pharm. Sci."},{"key":"BF01059033_CR5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/clinchem\/27.4.619","volume":"27","author":"S. M. Owens","year":"1981","unstructured":"S. M. Owens, A. J. McBay, H. M. Reisner, and M. Perez-Reyes. 125-I radioimmunoassay of delta-9-tetrahydrocannabinol in blood and plasma with a solid-phase second-antibody separation method.Clin. Chem. 27:619\u2013624 (1981).","journal-title":"Clin. Chem."},{"key":"BF01059033_CR6","unstructured":"M. Berman and M. F. Weiss.Users Manual for Simulation Analysis and Modeling. National Institutes of Health, DHEW (1977)."},{"key":"BF01059033_CR7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF01059266","volume":"9","author":"C. A. Hunt","year":"1981","unstructured":"C. A. Hunt, R. T. Jones, R. I. Herning, and J. Bachman. Evidence that cannabidiol does not significantly alter the pharmacokinetics of tetrahydrocannabinol in man.J. Pharmacokin. Biopharm. 9:245\u2013260 (1981).","journal-title":"J. Pharmacokin. Biopharm."},{"key":"BF01059033_CR8","first-page":"35","volume":"215","author":"C. A. Hunt","year":"1980","unstructured":"C. A. Hunt and R. T. Jones. Tolerance and disposition of tetrahydrocannabinol in man.J. Pharm. Exp. Ther. 215:35\u201344 (1980).","journal-title":"J. Pharm. Exp. Ther."},{"key":"BF01059033_CR9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/clpt.1980.181","volume":"28","author":"A. Ohlsson","year":"1980","unstructured":"A. Ohlsson, J. E. Lindgren, A. Wahlen, S. Agurell, L. E. Hollister, and H. K. Gillespie. Plasma delta-9-tetrahydrocannabinol concentrations and clinical effect after oral and intravenous administration and smoking.Clin. Pharmacol. Ther. 28:409\u2013416 (1980).","journal-title":"Clin. Pharmacol. Ther."},{"key":"BF01059033_CR10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00427095","volume":"74","author":"J. E. Lindgren","year":"1981","unstructured":"J. E. Lindgren, A. Ohlsson, S. Agurell, L. E. Hollister, and H. K. Gillespie. Clinical effects and plasma levels of delta-9-tetrahydrocannabinol in heavy and light users of cannabis.Psychopharmacology 74:208\u2013212 (1981).","journal-title":"Psychopharmacology"},{"key":"BF01059033_CR11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/bms.1200090103","volume":"9","author":"A. Ohlsson","year":"1982","unstructured":"A. Ohlsson, J. E. Lindgren, A. Wahlen, S. Agurell, L. E. Hollister, and H. K. Gillespie. Single dose kinetics of deuterium labeled delta-9-tetrahydrocannabinol in heavy and light cannabis users.Biomed. Mass Spectrom. 9:6\u201310 (1982).","journal-title":"Biomed. Mass Spectrom."},{"key":"BF01059033_CR12","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1007\/BF02085029","volume":"37","author":"S. Agurell","year":"1981","unstructured":"S. Agurell, J. E. Lindgren, A. Ohlsson, H. Gillespie, and L. E. Hollister. Interactions of delta-1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.Experientia 37:1090\u20131091 (1981).","journal-title":"Experientia"},{"key":"BF01059033_CR13","first-page":"764","volume":"32","author":"M. M. Halldin","year":"1982","unstructured":"M. M. Halldin, S. Carlsson, S. L. Kanter, M. Widman, and S. Agurell. Urinary metabolites of delta-1-tetrahydrocannabinol in man.Arzneim.-Forsch.\/Drug Res. 32:764\u2013768 (1982).","journal-title":"Arzneim.-Forsch.\/Drug Res."},{"key":"BF01059033_CR14","first-page":"1135","volume":"32","author":"M. M. Halldin","year":"1982","unstructured":"M. M. Halldin, L. K. R. Andersson, M. Widman, and L. E. Hollister. Further urinary metabolites of delta-1-tetrahydrocannabinol in man.Arzneim.-Forsch.\/Drug Res. 32:1135\u20131138 (1982).","journal-title":"Arzneim.-Forsch.\/Drug Res."}],"container-title":["Journal of Pharmacokinetics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01059033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01059033\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01059033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T13:43:27Z","timestamp":1586094207000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01059033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,10]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1982,10]]}},"alternative-id":["BF01059033"],"URL":"https:\/\/doi.org\/10.1007\/bf01059033","relation":{},"ISSN":["0090-466X"],"issn-type":[{"value":"0090-466X","type":"print"}],"subject":[],"published":{"date-parts":[[1982,10]]}}}